|
|
Nam Soo Joo, Hyung-Ju Cho, Monal Khansaheb, Jeffrey J. Wine
J Clin Invest. 2010;
120(9):3161
doi:10.1172/JCI43466
Abstract |
Full text
| PDF

C
ystic fibrosis (CF) results from mutations that disrupt CF transmembrane conductance regulator (CFTR), an anion channel found mainly in apical membranes of epithelial cells. CF leads to chronic infection of the airways with normally innocuous bacteria and fungi. Hypotheses to explain the pathophysiology of CF airways have been difficult to test because mouse models of CF do not develop human-like airway disease. The recent production of pigs lacking CFTR and pigs expressing the most common CF-causing CFTR mutant, ΔF508, provide another model that might help clarify the pathophysiology of CF airway disease. Here, we studied individual submucosal glands from 1-day-old piglets in situ in explanted tracheas, using optical methods to monitor mucus secretion rates from multiple glands in parallel. Secretion rates from control piglets (WT and CFTR+/–) and piglets with CF-like disease (CFTR–/– and CFTR–/ΔF508) were measured under 5 conditions: unstimulated (to determine basal secretion), stimulated with forskolin, stimulated with carbachol, stimulated with substance P, and, as a test for synergy, stimulated with forskolin and a low concentration of carbachol. Glands from piglets with CF-like disease responded qualitatively to all agonists like glands from human patients with CF, producing virtually no fluid in response to stimulation with forskolin and substantially less in response to all other agonists except carbachol. These data are a step toward determining whether gland secretory defects contribute to CF airway disease.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(7)
| Title and authors |
Publication |
Year |
Genetic therapies for cystic fibrosis lung disease
P. L. Sinn, R. M. Anthony, P. B. McCray
|
Human Molecular Genetics
|
2011 |
CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice
Weiliang Xie, John T. Fisher, Thomas J. Lynch, Meihui Luo, Turan I.A. Evans, Traci L. Neff, Weihong Zhou, Yulong Zhang, Yi Ou, Nigel W. Bunnett, Andrew F. Russo, Michael J. Goodheart, Kalpaj R. Parekh, Xiaoming Liu, John F. Engelhardt
|
J. Clin. Invest.
|
2011 |
Understanding protein kinase CK2 mis-regulation upon F508del CFTR expression
Andrea Venerando, Mario A. Pagano, Kendra Tosoni, Flavio Meggio, Diane Cassidy, Michelle Stobbart, Lorenzo A. Pinna, Anil Mehta
|
Naunyn-Schmied Arch Pharmacol
|
2011 |
Bacterial host interactions in cystic fibrosis
Máire Callaghan, Siobhán McClean
|
Current Opinion in Microbiology
|
2011 |
Oxidative stress and antioxidant therapy in cystic fibrosis
Francesco Galli, Andrea Battistoni, Roberto Gambari, Alfonso Pompella, Alessandra Bragonzi, Francesca Pilolli, Luigi Iuliano, Marta Piroddi, Maria Cristina Dechecchi, Giulio Cabrini
|
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
|
2011 |
Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent
Antje Munder, Florian Wölbeling, Tanja Kerber-Momot, Dirk Wedekind, Ulrich Baumann, Erich Gulbins, Burkhard Tümmler
|
Respir Res
|
2011 |
Transgenic animals may help resolve a sticky situation in cystic fibrosis
Jonathan H. Widdicombe
|
J. Clin. Invest.
|
2010 |
|